Emodin 6-O-β-D-glucoside

CAS No. 34298-85-6

Emodin 6-O-β-D-glucoside( Glucoemodin )

Catalog No. M24292 CAS No. 34298-85-6

Emodin 6-O-β-D-glucoside can protect barrier integrity and inhibit HMGB1-mediated inflammatory responses, which suggests a potential use as a therapy for sepsis or septic shock.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 201 In Stock
5MG 170 In Stock
10MG 275 In Stock
25MG 465 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Emodin 6-O-β-D-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Emodin 6-O-β-D-glucoside can protect barrier integrity and inhibit HMGB1-mediated inflammatory responses, which suggests a potential use as a therapy for sepsis or septic shock.
  • Description
    Emodin 6-O-β-D-glucoside can protect barrier integrity and inhibit HMGB1-mediated inflammatory responses, which suggests a potential use as a therapy for sepsis or septic shock. Emodin 6-O-beta-D-glucoside has anti-inflammatory activities and also may have significant therapeutic benefits against diabetic complications and atherosclerosis.
  • In Vitro
    Emodin-6-O-β-D-glucoside (0~20 μM; 24 hours; HUVECs) does not affect cell viability.Emodin-6-O-β-D-glucoside (0~10 μM; 6 hours; HUVECs) results in a dose dependent decrease in high glucose-mediated membrane disruption, inhibits high glucose-induced increase expression of VCAM-1, ICAM-1 and E-selectin and results in decreased expression levels of high glucose-induced MCP-1 and IL-8 mRNA.Emodin-6-O-β-D-glucoside (10 μM; 6 hours; HUVECs) results in a decrease in the number of THP-1 cells adhering to high glucose-induced HUVECs.Emodin-6-O-β-D-glucoside pretreatment significantly inhibits high-glucose-induced ROS formation and p65 NF-κB expression levels increase. Cell Viability Assay Cell Line:HUVECs Concentration:0~20 μM Incubation Time:24 hours Result:Did not affect cell viability.Western Blot Analysis Cell Line:HUVECs Concentration:0~10 μM Incubation Time:6 hours Result:Inhibited high glucose-induced increase expression of VCAM-1, ICAM-1 and E-selectin.RT-PCRCell Line:HUVECs Concentration:0~10 μM Incubation Time:6 hours Result:Resulted in decreased expression levels of high glucose-induced MCP-1 and IL-8 mRNA.Immunofluorescence Cell Line:HUVECsConcentration:10 μM Incubation Time:6 hours Result:Resulted in a decrease in the number of THP-1 cells adhering to high glucose-induced HUVECs.
  • In Vivo
    Emodin-6-O-β-D-glucoside (0~9 mg/mouse; i.v.) markly inhibits peritoneal leakage of dye induced by high glucose. Animal Model:Mouse Dosage:0~9 mg/mouse Administration:I.v.Result:Markly inhibited peritoneal leakage of dye induced by high glucose.
  • Synonyms
    Glucoemodin
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    34298-85-6
  • Formula Weight
    432.38
  • Molecular Formula
    C21H20O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc(cc1C(c2cc(O[C@@H]([C@@H]([C@H]3O)O)O[C@H](CO)[C@H]3O)cc(O)c22)=O)cc(O)c1C2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Moon C, et al. Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways. Respir Res. 2009 Mar 9;10(1):18.
molnova catalog
related products
  • Antitumor agent-87

    Antitumor agent-87 is a potent compound exhibiting high antitumoral activity, with a Ki value of 0.23 μM for CYP1A1.

  • NH2-C5-NH-Boc

    NH2-C5-NH-Boc (PROTAC Linker 23) is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.

  • [Tyr0]-Stresscopin (...

    [Tyr0]-Stresscopin (human)